671 - 680 of 8587 Results
Title
Year
-
RESTRICTEDTitle: Priorities in Parkinson's disease researchJournal Name: Nature Reviews Drug DiscoveryPublisher: Springer Science and Business Media LLCVol: 10Issue #: 5Start Page: 377End Page: 393Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nrd3430Citation Count: 369
-
RESTRICTEDTitle: ATP1A3-Related Disorders: An Ever-Expanding Clinical SpectrumJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.637890Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.637890/pdfCitation Count: 32
-
RESTRICTEDTitle: Neuroscience Training for the 21st CenturyJournal Name: NeuronPublisher: Elsevier BVVol: 90Issue #: 5Start Page: 917End Page: 926Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2016.05.030Best OA location URL: http://www.cell.com/article/S0896627316302094/pdfCitation Count: 59
-
RESTRICTEDTitle: The Search for a Peripheral Biopsy Indicator of α-Synuclein Pathology for Parkinson DiseaseJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol:Issue #:Start Page: nlw103End Page: nlw103Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlw103Best OA location URL: https://academic.oup.com/jnen/article-pdf/76/1/2/10325348/nlw103.pdfCitation Count: 48
-
RESTRICTEDTitle: Medicines for the Mind: Policy-Based “Pull” Incentives for Creating Breakthrough CNS DrugsJournal Name: NeuronPublisher: Elsevier BVVol: 84Issue #: 3Start Page: 554End Page: 563Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2014.10.027Best OA location URL: http://www.cell.com/article/S0896627314009477/pdfCitation Count: 64
-
RESTRICTEDTitle: Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?Journal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 5Start Page: 1369End Page: 1387Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-223183Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223183?id=journal-of-parkinsons-disease%2Fjpd223183Citation Count: 12
-
RESTRICTEDTitle: Overcoming obstacles in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 13Start Page: 1606End Page: 1611Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25260Citation Count: 44
-
RESTRICTEDTitle: Gait impairments in Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 18Issue #: 7Start Page: 697End Page: 708Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30044-4Citation Count: 399
-
RESTRICTEDTitle: Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseasesJournal Name: Progress in NeurobiologyPublisher: Elsevier BVVol: 214Issue #:Start Page: 102270End Page: 102270Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.pneurobio.2022.102270Best OA location URL: https://doi.org/10.1016/j.pneurobio.2022.102270Citation Count: 89
-
RESTRICTEDTitle: Mitochondria at the interface between neurodegeneration and neuroinflammationJournal Name: Seminars in Cell & Developmental BiologyPublisher: Elsevier BVVol: 99Issue #:Start Page: 163End Page: 171Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.semcdb.2019.05.028Citation Count: 73